Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryoablation with Sintilimab and Lenvatinib in Advanced ICC
NCT05835245Phase 2Recruiting
- Sponsor
- Fudan University
- Start
- Apr 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab, lenvatinib in intrahepatic cholangiocarcinoma (ICC), sponsored by Fudan University. Started Apr 2023; status: recruiting.
02
Drugs
sintilimablenvatinib
03
Conditions
intrahepatic cholangiocarcinoma (ICC)
Beyond the preview
Go deeper on NCT05835245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05835245.